Dr. scient. med. Nicole Grössmann-Waniek, MSc

Nicole Grössmann-Waniek has been working as a Senior Researcher at AIHTA (before LBI-HTA) since 2015. Her research focuses on evaluating the efficacy and safety of (new) oncological therapies to support evidence-based health policy decision-making. During her time at AIHTA, she has worked across a broad spectrum of HTA in the field of high-tech medicine. Most recently, she was involved in developing HTAs for the Austrian Appraisal Board for High-Cost and Specialised Hospital Medicines. Prior to that, she coordinated the Horizon Scanning in Oncology (HSO) programme.

In 2015, she completed her Master's degree in Behavioural, Neuro- and Cognitive Biology, specialising in neurobiology, at the University of Vienna. From October 2017 to May 2021, she was a doctoral candidate in the Department of Health Economics at the Centre for Public Health, Medical University of Vienna. Her dissertation focused on the clinical benefit of oncological therapies in Europe. Prior to joining AIHTA, she worked as a research project assistant at the Department of Neurobiology, University of Vienna.